Logo

SeraCare Seraseq Solid Tumor Mutation Mix-I

Oct 16, 2015

SeraCare Life Sciences has launched the Seraseq Solid Tumor Mutation Mix-I (AFI-10) a reference material for next-generation sequencing-based tumor profiling assays. The kit contains the same mixture of mutations in key oncogenes and tumor suppressor genes as in the previously launched AF20 mix, but is offered at five additional allele frequencies, SeraCare said. By offering a set of material at 10, 8, 5, 3, and 1 percent allele frequency, this product enables laboratories to test their lower limit of variant frequency against a known and well-characterized reference material, the company added.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.